A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease with diverse clinical manifestations characterized by the development of pathogenic autoantibodies manifesting in inflammation of target organs such as the kidneys, skin and joints. Genome-wide association studies have identified genetic va...
Saved in:
Published in: | Genes and immunity Vol. 13; no. 5; pp. 380 - 387 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
London
Nature Publishing Group UK
01-07-2012
Nature Publishing Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Systemic lupus erythematosus (SLE) is an autoimmune disease with diverse clinical manifestations characterized by the development of pathogenic autoantibodies manifesting in inflammation of target organs such as the kidneys, skin and joints. Genome-wide association studies have identified genetic variants in the
UBE2L3
region that are associated with SLE in subjects of European and Asian ancestry.
UBE2L3
encodes an ubiquitin-conjugating enzyme, UBCH7, involved in cell proliferation and immune function. In this study, we sought to further characterize the genetic association in the region of
UBE2L3
and use molecular methods to determine the functional effect of the risk haplotype. We identified significant associations between variants in the region of
UBE2L3
and SLE in individuals of European and Asian ancestry that exceeded a Bonferroni-corrected threshold (
P
<1 × 10
−4
). A single risk haplotype was observed in all associated populations. Individuals harboring the risk haplotype display a significant increase in both
UBE2L3
mRNA expression (
P
=0.0004) and UBCH7 protein expression (
P
=0.0068). The results suggest that variants carried on the SLE-associated
UBE2L3
risk haplotype influence autoimmunity by modulating UBCH7 expression. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 These authors jointly directed this work. These authors contributed equally to this work. |
ISSN: | 1466-4879 1476-5470 1476-5470 |
DOI: | 10.1038/gene.2012.6 |